Oncolys BioPharma Inc.
TSE:4588.T
709 (JPY) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 2,165.918 | 1,287.763 | 1,711.28 | 3,454.714 | 2,067.927 | 3,342.585 | 2,463.138 | 2,867.512 | 2,564.045 | 3,605.286 | 4,727.483 | 5,579.61 | 696.975 |
| Short Term Investments
| 245.083 | 245.081 | 245.079 | 245.078 | 245.077 | 245.07 | 245.064 | 945.058 | 1,145.051 | 1,545.033 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 2,411.001 | 1,532.844 | 1,711.28 | 3,454.714 | 2,067.927 | 3,342.585 | 2,463.138 | 2,867.512 | 2,564.045 | 3,605.286 | 4,727.483 | 5,579.61 | 696.975 |
| Net Receivables
| 0 | 101.745 | 318.404 | 352.148 | 70.598 | 217.331 | 109.661 | 88.736 | 97.287 | 23.985 | 60.34 | 14.927 | 9.936 |
| Inventory
| 4.578 | 5.342 | 24.249 | 11.656 | 10.472 | 14.917 | 11.062 | 18.58 | 15.118 | 15.711 | 18.781 | 21.613 | 18.051 |
| Other Current Assets
| 682.665 | 417.697 | 554.821 | 355.007 | 299.69 | 251.596 | 34.254 | 63.947 | 70.068 | 28.72 | 78.127 | 15.096 | 5.749 |
| Total Current Assets
| 3,098.244 | 1,955.883 | 2,608.754 | 4,198.008 | 2,545.676 | 3,826.429 | 2,618.115 | 3,071.713 | 2,746.518 | 3,673.702 | 4,884.731 | 5,631.246 | 730.711 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 21.149 | 21.22 | 42.547 | 39.356 | 30.555 | 31.718 | 29.98 | 77.981 | 95.819 | 49.751 | 58.703 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0.65 | 0.85 | 0 | 0 | 0 | 4.132 | 0.853 | 1.261 | 1.669 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0.65 | 0.85 | 0 | 0 | 0 | 4.132 | 0.853 | 1.261 | 1.669 |
| Long Term Investments
| 21.036 | 21.036 | 21.036 | 55.539 | 143.524 | 430.586 | 780.556 | 421.546 | 362.213 | 280.003 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | -143.524 | -430.586 | 0 | 0 | 0 | -280.003 | 0 | 0 | 0 |
| Other Non-Current Assets
| 79.578 | 63.679 | 0.019 | 17.109 | 207.539 | 513.421 | 0.884 | 1.242 | 1.601 | 250.141 | 27.356 | 14.392 | 9.282 |
| Total Non-Current Assets
| 100.614 | 84.715 | 42.204 | 93.868 | 250.736 | 553.627 | 811.995 | 454.506 | 393.794 | 332.254 | 124.028 | 65.404 | 69.654 |
| Total Assets
| 3,198.858 | 2,040.598 | 2,650.959 | 4,291.876 | 2,796.413 | 4,380.056 | 3,430.112 | 3,526.222 | 3,140.313 | 4,005.959 | 5,008.761 | 5,696.651 | 800.366 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 52.287 | 193.354 | 60.858 | 106.247 | 0 | 0 | 71.012 | 88.74 | 89.739 | 43.944 | 40.826 | 36.57 | 10.098 |
| Short Term Debt
| 137.953 | 135.341 | 231.357 | 241.554 | 152.152 | 130.923 | 89.131 | 103.158 | 73.151 | 103.795 | 183.044 | 159.727 | 63.66 |
| Tax Payables
| 0 | 18.844 | 2.931 | 59.242 | 33.486 | 119.687 | 35.933 | 32.826 | 24.634 | 10.483 | 12.136 | 18.359 | 7.82 |
| Deferred Revenue
| 0 | 0 | -60.858 | -106.247 | -206.61 | -253.275 | -71.012 | -88.74 | 36.801 | 25.038 | 35.741 | 28.047 | 13.999 |
| Other Current Liabilities
| 62.15 | 30.992 | 26.493 | 23.168 | 229.606 | 273.191 | 16.248 | 14.311 | 17.325 | 18.658 | 26.865 | 18.272 | 9.144 |
| Total Current Liabilities
| 252.39 | 378.531 | 321.639 | 430.211 | 415.244 | 523.801 | 212.324 | 239.035 | 204.849 | 176.966 | 262.871 | 232.928 | 90.722 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 186.687 | 179.829 | 162.302 | 261.916 | 372.923 | 397.299 | 312.449 | 351.58 | 315.297 | 324.96 | 365.751 | 358.522 | 228.218 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.699 | 8.189 | 7.564 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.954 | 3.352 | 1.386 |
| Other Non-Current Liabilities
| 7.572 | 8.141 | 7.749 | 5.757 | 4.92 | 4.909 | 4.185 | 3.712 | 2.784 | 2.562 | 0.001 | 0.001 | 0.001 |
| Total Non-Current Liabilities
| 194.259 | 187.97 | 170.051 | 267.673 | 377.843 | 402.208 | 316.634 | 355.292 | 318.081 | 327.522 | 374.405 | 370.064 | 237.169 |
| Total Liabilities
| 446.649 | 566.501 | 491.69 | 697.884 | 793.087 | 926.009 | 528.958 | 594.327 | 522.93 | 504.488 | 637.276 | 602.992 | 327.891 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 2.799 | 5.477 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 5,108.16 | 3,623.165 | 3,000 | 9,039.516 | 7,436.537 | 7,121.273 | 6,402.658 | 5,802.444 | 5,090.981 | 5,072.338 | 5,072.278 | 5,059.448 | 2,442.98 |
| Retained Earnings
| -5,057.978 | -3,373.199 | -1,434.694 | -14,516.735 | -12,901.296 | -10,806.209 | -9,893.863 | -8,660.016 | -7,569.313 | -6,637.915 | -5,780.624 | -5,041.625 | -4,406.071 |
| Accumulated Other Comprehensive Income/Loss
| 7.68 | 0 | 7.68 | 7.68 | 7.496 | 15.56 | -2.799 | -5.477 | 12.234 | 10,137.176 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 2,694.347 | 1,224.131 | 586.283 | 9,063.531 | 7,468.085 | 7,138.983 | 6,389.56 | 5,783.99 | 5,083.481 | 5,064.838 | 5,064.778 | 5,075.836 | 2,435.48 |
| Total Shareholders Equity
| 2,752.209 | 1,474.097 | 2,159.269 | 3,593.992 | 2,003.326 | 3,454.047 | 2,901.154 | 2,931.895 | 2,617.383 | 3,501.471 | 4,371.485 | 5,093.659 | 472.475 |
| Total Equity
| 2,752.209 | 1,474.097 | 2,159.269 | 3,593.992 | 2,003.326 | 3,454.047 | 2,901.154 | 2,931.895 | 2,617.383 | 3,501.471 | 4,371.485 | 5,093.659 | 472.475 |
| Total Liabilities & Shareholders Equity
| 3,198.858 | 2,040.598 | 2,650.959 | 4,291.876 | 2,796.413 | 4,380.056 | 3,430.112 | 3,526.222 | 3,140.313 | 4,005.959 | 5,008.761 | 5,696.651 | 800.366 |